image dons

I make a donation

STEMI P2Y12

To compare the effect on platelet reactivity of ticagrelor 90 mg twice daily and prasugrel 10 mg once daily in patients with STEMI

Terminée

La Grande Journée du Coeur (22 juin 2022)
Attention : plus que quelques places restantes !

Colloquium : Pathologies cardiaques de la femme (15 novembre 2022)
Inscriptions ouvertes !

logo étude

objectif

To compare the effect on platelet reactivity of ticagrelor 90 mg twice daily and prasugrel 10 mg once daily in patients with STEMI, using PRU measurement by VerifyNow®, VASP phosphorylation and measurement of residual platelet aggregation by light transmission aggregometry (LTA).

date de réalisation

2014

nombre de patients

118

nombre de centres participants

Monocentrique (Pitié-Salpêtrière)

type de financement

Public (INSERM) et privé (Groupe ACTION)

Référence

-

Autres études

+

BIO-TAVI

En cours


Correlation between the platelet reactivity, the von Willebrand factor and bleeding and thrombotic events occuring during the year following TAVI
+

AMUNDSEN

En cours


A phase IV, multicentric, randomized, real-world pragmatic study that compares a strategy of early LDL reduction with anti-PCSK9 in patients defined as extreme high risk by 2019 ESC/EAS guidelines vs....
+

AFLOAT

En cours


To assess if flecainide is more efficient than standard of care (control group) to prevent AF occurrence during the 3 months after PFO closure.